Exploring Early Breast Cancer: Advancing Research Across the Treatment Journey
Explore how research in early breast cancer is advancing understanding across the treatment journey. Learn how treatment response, residual invasive disease, biomarkers and recurrence risk are informing research, and how innovative approaches such as antibody-drug conjugates (ADCs) are being investigated earlier in breast cancer. Discover how Daiichi Sankyo is advancing breast cancer research to address unmet patient needs.
